XML 23 R6.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning balance, (in shares) at Dec. 31, 2022   139,159,534      
Beginning balance at Dec. 31, 2022 $ 1,116,780 $ 14 $ 2,068,225 $ (2,316) $ (949,143)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   1,371,834      
Exercise of stock options 17,630   17,630    
Stock-based compensation 184,552   184,552    
Issuance of common stock upon settlement of restricted stock units (in shares)   3,699,168      
Issuance of common stock upon settlement of restricted stock units 1 $ 1      
Issuance of common stock for employee stock purchase plan (in shares)   575,928      
Issuance of common stock upon settlement of restricted stock units 25,400   25,400    
Other comprehensive income (loss) 941     941  
Net loss (189,694)       (189,694)
Ending balance, (in shares) at Dec. 31, 2023   144,806,464      
Ending balance at Dec. 31, 2023 1,155,610 $ 15 2,295,807 (1,375) (1,138,837)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   1,187,141      
Exercise of stock options 15,773   15,773    
Stock-based compensation 200,219   200,219    
Issuance of common stock upon settlement of restricted stock units (in shares)   3,393,832      
Issuance of common stock upon settlement of restricted stock units   $ 0      
Issuance of common stock for employee stock purchase plan (in shares)   465,698      
Issuance of common stock upon settlement of restricted stock units 24,069   24,069    
Other comprehensive income (loss) (1,362)     (1,362)  
Net loss (105,956)       (105,956)
Ending balance, (in shares) at Dec. 31, 2024   149,853,135      
Ending balance at Dec. 31, 2024 $ 1,288,353 $ 15 2,535,868 (2,737) (1,244,793)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares) 1,087,885 1,087,885      
Exercise of stock options $ 11,810   11,810    
Stock-based compensation 258,041   258,041    
Issuance of common stock upon settlement of restricted stock units (in shares)   3,507,912      
Issuance of common stock for employee stock purchase plan (in shares)   447,537      
Issuance of common stock upon settlement of restricted stock units 26,332   26,332    
Shares withhold related to net share settlement of equity awards (in shares)   (1,284,051)      
Shares withhold related to net share settlement of equity awards $ (94,119)   (94,119)    
Repurchase and retirement of common stock, including transaction costs and excise tax (in shares) (1,903,854) (1,903,854)      
Repurchase and retirement of common stock, including transaction costs and excise tax $ (128,839)   (128,839)    
Other comprehensive income (loss) 1,467     1,467  
Net loss (100,783)       (100,783)
Ending balance, (in shares) at Dec. 31, 2025   151,708,564      
Ending balance at Dec. 31, 2025 $ 1,262,262 $ 15 $ 2,609,093 $ (1,270) $ (1,345,576)